COVID-19: Epidemiology and Preventive Measures in Jiangsu Province, China

Background To discuss the epidemiological features of coronavirus disease 2019(COVID-19) and prevention measures in Jiangsu Province. Methods Information on all novel coronavirus pneumonia confirmed cases in Jiangsu was collected from the official website of Jiangsu Commission of Health. All data are entered into Excel and Python3 for statistical analysis. Epidemiological characteristics of novel coronavirus pneumonia confirmed cases from January 10, 2020 to March 18th in Jiangsu province were retrospectively analyzed. Meanwhile, the preventive measures of Jiangsu Commission of Health and the people's Government of Jiangsu Province were also analyzed. Results 631 COVID-19 cases were diagnosed in Jiangsu Province, covering 13 districts in Jiangsu. Before February 1, the confirmed cases were mainly imported cases, and after February 1, community transmission cases became main part of confirmed cases. There were more male patients than females, and most patients were in the group of 30-70 years old, 49 patients (7.8%) with mild symptom and 572 patients (90.6%) with common type accounted for the majority. The cumulative mortality rate was 0% and the cure rate was 100%. Reasonable treatment, timely and effective preventive measures were taken to effectively improve cure rate and to prevent the spread of the epidemic, all measures ensure the health and life safety of the people. Conclusion The preventive measures in Jiangsu Province were timely and effective, the epidemic situation in Jiangsu Province had been well controlled and cured.

COVID-19: epidemiology and preventive measures in Jiangsu province, China

Background: To investigate the epidemiological features of coronavirus disease 2019(COVID-19) and the prevention measures in Jiangsu Province. Methods: Information of all novel coronavirus pneumonia confirmed cases in Jiangsu was collected from the official website of Jiangsu Commission of Health. All data were entered into Excel and Python3 for statistical analysis. Epidemiological characteristics of novel coronavirus pneumonia confirmed cases from January 10, 2020 to March 18 in Jiangsu province were retrospectively analyzed. Meanwhile, the preventive measures of Jiangsu Commission of Health and the people’s Government of Jiangsu Province were also analyzed. Results: 631 COVID-19 cases were diagnosed in Jiangsu Province, covering 13 cities in Jiangsu. Before February 1, the confirmed cases were mainly imported cases, and after February 1, community transmission cases became main part of confirmed cases. There were more male patients than females, and most patients were in the group of 30-70 years old, 49 patients (7.8%) with mild symptom and 572 patients (90.6%) with common type accounted for the majority. The cumulative mortality rate was 0% and the cure rate was 100%. Reasonable treatments, timely and effective preventive measures were taken to effectively improve cure rate and to prevent the spread of the epidemic, all measures ensure the health and life safety of the people. Conclusion: The preventive measures in Jiangsu Province were timely and effective, the epidemic situation in Jiangsu Province had been well controlled.

A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. Although surgery is known as the most promising radical treatment, a high recurrent or metastatic rate after surgery has limited its clinical efficacy. Sorafenib, a target agent, has seemed to be the only option for metastatic HCC patients to date, but none of clinical trials showed it could prolong the overall survival (OS) of advanced HCC to 1 year. How to prolong the OS and improve cure rate of HCC patients is still beset with difficulties. This report presents a rare case of recurrent HCC patient with complete regression of target lesion with 2 years of Chinese herbal treatment. A 64-year-old Chinese man with hepatitis B virus–associated chronic hepatitis presented HCC has been clinically diagnosed tumor relapse and omentum metastasis with computed tomography and α-fetoprotein blood test 4 months after surgery. It was decided the patient would receive traditional Chinese medicine treatment because of poor prognosis. After approximately 2 years of treatment, recurrent hepatic tumor and omentum metastasis have been found in complete regression. The patient remains alive over 31 months after relapse.